Citigroup’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-100
| Closed | – | – | 5350 |
|
|
2022
Q3 | $0 | Sell |
100
-5,900
| -98% | – | ﹤0.01% | 5788 |
|
|
2022
Q2 | $4K | Buy |
+6,000
| New | +$4K | ﹤0.01% | 4961 |
|
|
2021
Q2 | – | Sell |
-1,042
| Closed | -$4K | – | 5755 |
|
|
2021
Q1 | $4K | Sell |
1,042
-1,455
| -58% | -$5.59K | ﹤0.01% | 5307 |
|
|
2020
Q4 | $8K | Buy |
2,497
+1,764
| +241% | +$5.65K | ﹤0.01% | 4938 |
|
|
2020
Q3 | $3K | Sell |
733
-1,390
| -65% | -$5.69K | ﹤0.01% | 4880 |
|
|
2020
Q2 | $10K | Sell |
2,123
-1,748
| -45% | -$8.23K | ﹤0.01% | 4653 |
|
|
2020
Q1 | $13K | Buy |
3,871
+1,119
| +41% | +$3.76K | ﹤0.01% | 4557 |
|
|
2019
Q4 | $17K | Buy |
2,752
+2,072
| +305% | +$12.8K | ﹤0.01% | 4550 |
|
|
2019
Q3 | $2K | Sell |
680
-3,164
| -82% | -$9.31K | ﹤0.01% | 4987 |
|
|
2019
Q2 | $50K | Buy |
+3,844
| New | +$50K | ﹤0.01% | 4100 |
|
|
2019
Q1 | – | Sell |
-113,605
| Closed | -$351K | – | 5198 |
|
|
2018
Q4 | $351K | Buy |
+113,605
| New | +$351K | ﹤0.01% | 2760 |
|